Description
Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ interviews Dr. Sarah Hudson-DiSalle, member of the Reimbursement and Economics Subcommittee of ACCC’s Governmental Affairs Committee, about this week’s Hill Day, when members of ACCC met with Capitol Hill offices to advocate on behalf of patients. Guest:
Sarah Hudson-DiSalle, RPh, PharmD
Assistant Director of Infusion Reimbursement
The James Cancer Hospital, Columbus, Ohio
Issues Discussed on Capitol Hill this week:
Oncology Patient Navigation
Financial Toxicity for Patients with Cancer
Oncology Drug Shortage
Inflation Reduction Act (IRA)
Resources:
ACCC Legislative Action Center
ACCC Committees: Get Involved
The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In...
Published 09/19/24
Advancements in treatment combined with a multimodal approach are improving outcomes for patients with head and neck cancer. However, the unique challenges of a head and neck cancer diagnosis and its treatment side effects—such as speech and communication difficulties as well as negative effects...
Published 09/12/24